Default company panoramic image

Bone Therapeutics

Bone Therapeutics is a private Walloon company focused on cell therapy for bone diseases.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Charleroi, Walloon Region, Belgium
  • Currency EUR
  • Founded June 2006
  • Employees 40
  • Website

Company Summary

Development of novel therapeutic bone cell products administrable by a minimally invasive technique for the treatment of invalidating bone diseases. Bone disease and reconstruction market is one of the largest healthcare markets in the world, with more than 4M procedures requiring bone grafts annually. Bone Therapeutics is operating in areas where demand for new products is high and competition is low.


  • Default avatar
    Enrico Bastianelli
    MD, MBA

    Bone Therapeutics CEO, ex VP Corporate Development at ProSkelia/ProStrakan (spin-out of Aventis), ex McKinsey & Co Consultant

  • Default avatar
    Valérie Gangji
    MD, PhD

    Bone Therapeutic Scientific experts, Head of Rheumatology (Erasme Hospital, Brussels), In charge of the bone cell therapy program and pain clinic


  • Default avatar
    Stibbe Law Firm
    Default avatar
    Myriam Piscitello (Financial Manager), Deloitte et Mazars (Commissaires aux comptes)

Previous Investors

  • Default avatar
    Theodorus, La Compagnie du Bois Sauvage, Sambrinvest, BAMS Angel Fund I
    Default avatar
    Nausicaa Ventures, La Société Régionale d'investissement de Wallonie (SRIW)
    Default avatar
    Life Science Research Partners, investisseurs privés